Rx Drug Pricing Bootcamp

Topics: Addressing Fraud and Abuse Concerns Arising Under Part D (W. Goldstein, 11/17); Part D Formulary Negotiations and Contracting: What Have We Learned and Where Are We Going? (L. Snyder, 11/17)

This event is CLE approved

Brochure